German defense giant Rheinmetall cut its full-year 2026 guidance on Wednesday, citing delays to military contracts and ammunition deliveries, marking the company's second outlook reduction since August [1]. The company now expects 2026 sales of approximately 13.2 billion euros ($14.9 billion), down from a prior range of 13.7 to 14.2 billion euros, with operating margin projected at 18.5% versus the previously expected 19% [1]. The revision stems from delays in the German military's Arminius Boxer project, now expected to be commissioned in the following year, and setbacks in artillery ammunition acceptance testing [1].
The announcement triggered a sharp market reaction, with shares falling over 15% in early trading [1]. This decline is particularly significant given the stock's broader performance trajectory: shares are down approximately 35% year-to-date, despite averaging annual gains of 114% over the prior four years as Rheinmetall became a primary beneficiary of increased European military spending following Russia's 2022 invasion of Ukraine [1]. RBC analysts characterized the announcement as "clearly negative," expressing concerns about the Boxer program's timing and scope, and warning that the news could fuel broader investor concerns about traditional defense technology versus newer alternatives [1].
Despite the guidance cut, Rheinmetall's third-quarter results showed operational strength, with sales increasing 32% year-on-year to 3.15 billion euros and operating profit jumping 62% to 553 million euros [1]. The company reported new order intake of 2.89 billion euros and a substantial backlog of 78 billion euros by quarter-end [1]. However, these positive operational metrics were overshadowed by execution concerns, as RBC analysts suggested investors may view the delays as evidence of the "new-tech vs old-tech" sector debate [1].
CONCLUSION
Rheinmetall's second guidance cut in four months signals execution challenges in key military programs despite strong order intake and backlog, triggering a 15% stock decline. The market's sharp reaction reflects growing concerns about the company's ability to deliver on defense contracts amid geopolitical demand, potentially impacting investor confidence in traditional defense contractors relative to emerging technologies.